Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 562
DIABETES MELLITUS TYPE I OR TYPE II INSULIN TREATED - CGM OPTION PROTOCOL
H. FREQUENTLY ASKED QUESTIONS (FAQs) (Page 1 of 4)
(Updated 08/30/2023)
POLICY FAQs
1. What did it take to develop an insulin-use policy for Class I and II medical certificate for
the FAA?
Advances in diabetes management utilizing CGM technology provides pilots and the FAA better
information about blood glucose levels and advanced warning of potentially dangerous glucose
levels before they occur. CGM technology also allows the FAA to evaluate consistency of blood
glucose control both in flight and on the ground.
2. Why did the FAA take so long to develop an insulin-use policy for Class I/II airmen
especially when other countries have allowed it for years?
Various flight safety considerations for this serious health condition could not be safely mitigated
for commercial operations until recently. Advances in technology and diabetes management
now provide the FAA better parameters to consider Class I and II medical certification for some
insulin-dependent airmen.
At the time of initial publication, only Canada and the United Kingdom allow the use of insulin in
their pilots with an equivalent Class I or II medical. Unlike the FAA, those aviation authorities can
impose specific operational limitations on the medical certificate (e.g., “valid only for two pilot
operations” or requiring the other pilot to be both aware of the diabetic condition and able to
provide emergency treatment.)
3. Why is the FAA so restrictive and why is there so much testing?
The FAA policy follows current medical standards of care for diabetes to ensure pilots are safe to
fly in the complex aviation environment and reduce the risks of end-organ damage. If the latter is
present, the potential risk of cognitive impairment is increased, which could be magnified in a
hypoxic or high-stress environment, affecting safety.
4. My doctor says my diabetes is well controlled and that I have no limitations. Why doesn’t
FAA accept that?
While your physicians understand how to keep your blood sugar stable while on the ground, they
may not be familiar with the additional challenges of the demanding aviation environment and
may not consider them when determining clinical limitations. FAA guidance addresses these
aviation-specific concerns.
5. Are there additional risks when flying with diabetes?
Yes. Hypoglycemia can lead to cognitive impairment, loss of consciousness, and seizure.
Hyperglycemia can potentially cause sudden incapacitation, but it can also cause damage to
eyes, heart, kidneys, and nervous system.
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
FAA Guide for Aviation Medical Examiners, Version 10/28/2026, page 562. AME Copilot is an independent reference tool, not affiliated with or endorsed by the FAA. The FAA AME Guide is the authoritative source.